ArticleAmerican journal of translational research2015

Low molecular weight fucoidan ameliorates diabetic nephropathy via inhibiting epithelial-mesenchymal transition and fibrotic processes.

Jihui Chen et al.PubMed ↗Full text ↗

No numbers read from the abstract.